Related Experiment Video

Updated: Jul 12, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

Sudden cardiac death: epidemiology, mechanisms, and therapy

Mintu Turakhia1, Zian H Tseng

  • 1University of California, San Francisco, USA.

Current Problems in Cardiology
|August 29, 2007
PubMed

Insights

Sudden cardiac death (SCD) is a significant public health issue. Identifying new markers beyond ejection fraction is crucial for effective primary prevention strategies.

Area of Science:

  • Cardiology
  • Public Health
  • Medical Research

Background:

  • Sudden cardiac death (SCD) affects 500,000 annually in the US, primarily linked to coronary artery disease and reduced ejection fraction.
  • Global incidence is rising due to increasing prevalence of heart failure and coronary artery disease.
  • SCD is heterogeneous, with causes including ischemia, structural defects, myocardial scar, genetic mutations, and can occur in structurally normal hearts.

Purpose of the Study:

  • To review the epidemiology, mechanisms, etiologies, and therapies for sudden cardiac death.
  • To discuss current treatment guidelines and explore future directions in SCD management.
  • To highlight the need for improved patient selection for primary prevention therapy beyond ejection fraction.

Main Methods:

  • Literature review of epidemiology, pathophysiology, and clinical management of sudden cardiac death.
  • Analysis of current therapeutic strategies including beta-blockers and implantable cardioverter defibrillators.
  • Examination of novel biomarkers for risk stratification.

Main Results:

  • Ejection fraction is a primary but insufficient criterion for defibrillator implantation.
  • Novel clinical, electrophysiologic, and genetic markers show promise for improving patient selection.
  • Beta-blockers reduce SCD risk; implantable cardioverter defibrillators terminate malignant arrhythmias.

Conclusions:

  • Sudden cardiac death remains a critical health challenge with increasing incidence.
  • Current risk stratification methods are limited, necessitating the exploration of new markers.
  • Advancing the understanding and application of novel markers will enhance primary prevention strategies for sudden cardiac death.

More Related Videos

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease12:15

Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease

Published on: February 8, 2022

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...